期刊文献+

高肺血流幼猪模型中肺动脉血流动力学及组织学变化对血清基质金属蛋白酶的影响

Impact of pulmonary hypertension induced high pulmonary blood flow on matrix metalloproteinase in piglet model
下载PDF
导出
摘要 目的研究高肺血流幼猪模型肺动脉血流动力学及组织学变化与血清基质金属蛋白酶的关联性。方法采用生后2-3月龄的幼猪,体重7-10kg,分为两组,每组12只。对照组(control group,n=12):即假手术组,只开胸无手术处理;高肺血流组(shunt group,n=12):全部行左侧开胸,降主动脉与左肺动脉搭桥术。所有动物正常饲养3个月。然后正中开胸,检测肺动脉收缩压(PASP)、肺血管阻力(PVR),观察肺动脉标本的结构和组织学变化。Elisa检测血清基质金属蛋白酶水平。结果高肺血流组肺动脉收缩压(PASP)、肺血管阻力(PVR)显著升高(P<0.01);左肺动脉出现平滑肌细胞显著增生,部分血管中膜及内膜增厚,官腔狭窄;血清基质金属蛋白酶水平升高。结论在幼猪动物模型中,高肺血流可导致肺动脉结构重塑,可导致肺动脉压力的升高,与血清基质金属蛋白酶变化呈正相关。为进一步研究高肺血流先天性心脏病肺动脉高压的形成过程提供实验依据以及实验平台,以期在治疗上提供新的方法。 Objective To research the relation of blood serum matrix metalloproteinase 9(MMP9)and pulmonary artery pressure and structure in the high pulmonary blood piglet models.Methods Piglets the age of 2-3 months and weighs 7-10 kg were divided into two groups randomly,each group of 12.the only Control group(n=12),or sham group,only that have not been dealt with the operation of the lungs set;High pulmonary blood group(shunt group,n=12):all the line left open,cut to the left pulmonary artery bypass surgery.All animals are normally raise three months,then the open,and testing pulmonary arterial systolic pressure(PASP)and pulmonary vascular resistance(PVR),observing the organization of pulmonary artery;testing MMP9.Results In shunt group,pulmonary arterial systolic pressure(pasp)and pulmonary vascular resistance(PVR)significantly increased(P〈0.01),Smooth muscle cells in left pulmonary artery were shown in remarkably,in part of the tunicae intima vasorum thickend.MMP9 significantly increased(P〈0.01);In Control group,no apparent change of pulmonary arterial systolic pressure and pulmonary vascular resistance and MMP9.Conclusion In piglet models,high lung blood flow could induce the reshaping of the pulmonary artery structure and pulmonary hypertension,could lead to MMP9 significantly increasing.To further study the formation of high pulmonary blood flow in congenital heart disease with pulmonary hypertension process provides experimental basis,with a view to offer new methods on the treatment.
出处 《中国实验诊断学》 2012年第9期1572-1574,共3页 Chinese Journal of Laboratory Diagnosis
基金 吉林省科技厅科技发展计划项目资助课题(20050408-04)
关键词 高肺血流肺动脉高压 幼猪模型 血清基质金属蛋白酶 high pulmonary blood pulmonary hypertension piglet model matrix metalloproteinase 9
  • 相关文献

参考文献5

  • 1vy DD, MeMurtry IF, Colvin K, et al. Development of Occlusive Neointimal Lesions in Distal Pulmonary Arteries of Endothelin P, Receptor-Deficient Rats:A New Model of Severe Pulmonary Ar terial Hypertension[J]. Circulation, 2005,111 (22) : 2988.
  • 2Grover TR, Zenge JP, Parker TA, et al. Vascular Endothelial Growth Factor Causes Pulmonary Vasodilation through Activa tion of the Phosphatidylinositol-3-Kinase Nitric Oxide Pathway in the Late-Gestation Ovine Fetu[J].Pediatric Research, 2002,52 (6):907.
  • 3Masumoto K, de Rooij JD, Suita S, et al. Expression of matrix metelloproteinases and tissue inhibitors of metalloproteinases during normal human pulmonary developmen[J]. Histopatholo gy,2005,47(4) :410.
  • 4Wang H,Metha JL,Chen K,et al. Human Urotensin II Modu lares Collagen Synthesis and the Expression of MMP 1 in Human Endothelial Cells[J]. J Cardiovase Pharmacol, 2004,44 (5) : 577.
  • 5曾红军,庞玉生,梁秀安,于丽娟,武艺飞.小儿先天性心脏病并肺动脉高压血清基质金属蛋白酶与其组织抑制物的变化[J].中国实用儿科杂志,2008,23(10):740-743. 被引量:3

二级参考文献9

  • 1Rabinovitch M, Bothwell T, Hayakawa N, et al. Pulmonary arterial abnormalities in patients with congenital heart defects and pulmonary hypertension[J]. Lab Invest 1986,55 (6) :632-653.
  • 2Kolpakov V, Rekhter MD, Gordon D, et al. Effect of mechanical forces on growth and matrix protein synthesis in the in vitro pulmonary artery[J]. Cite Res,1995,77(4) :823-831.
  • 3Kenagy RD, Vergel S, Mattsson E, et al. The role of plasminogen, plasminogen ativators, and matrix metalloproteinases in primate arterial smooth muscle cell migration [ J ]. Am Heart Assoc, 1996, 16(11) : 1373-1382.
  • 4Niedzwiecki L,Teahan J, Harrison R K, et al. Substrate-specificity of the human matrix metalloproteinase stromelysin and the development of continuous fluorometric assays [ J ]. Biochemistry, 1992,31 (50) : 12618-12623.
  • 5Adatia I, Barrow SE, Stratton PD, et al. Vascular endothelial re- sponses, prostanoids ,and flow: thromboxane A sub-2 and prostacyclin biosynthesis in children and adolescents with pulmonary vascular disease[ J ]. Circulation, 1993,88 (5) :2117-2122.
  • 6Schermuly RT, Kreisselmeier KP, Ghofrani HA, et al. Antiremodeling effects of iloprost and the dual-selective phosphodiesterase 3/4 inhibitor tolafentrine in chronic experimental pulmonary hypertension [ J ]. Circ Res ,2004,94 ( 8 ) : 1101-1108.
  • 7Carmosino MJ, Friesen RH, Doran A, et al. Perioperative complication in children with pulmonary hypertention Undergoing non- cardiac surgery or cardiac catheterization [ J ]. Anesth Analg, 2007,104(3 ) :521-527.
  • 8秦玉明,周爱卿,贲晓明,沈捷,梁瑛,李奋.间质胶原酶在实验性肺高压肺血管重建中表达的动态改变[J].上海医学,2001,24(11):667-670. 被引量:4
  • 9巩性军,秦天庆,李守先,张廷国,张希全,杨长勇.前列腺素E_1对先心病重度肺动脉高压患者肺组织结构的影响[J].山东医药,2002,42(10):13-14. 被引量:4

共引文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部